Healthcare Realty Trust INC 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Healthcare Realty Trust Incorporated has replaced its existing shelf registration statement with a new one and continues its at-the-market equity offering program.
NYSE
Healthcare Realty Trust Incorporated held its annual stockholder meeting on May 19, 2026, with high participation and votes on director elections, auditor ratification, and executive compensation.
NYSE
Healthcare Realty Trust Incorporated has entered into a $400 million senior unsecured delayed draw term loan facility to enhance its financial flexibility.
NYSE
Healthcare Realty Holdings, L.P. has issued $700 million in 3.00% Exchangeable Senior Notes due 2032, guaranteed by Healthcare Realty Trust Incorporated, with provisions for exchange into common stock and redemption options.
NYSE
Healthcare Realty Trust Incorporated announced the pricing of its $600 million offering of exchangeable senior notes due 2032, with proceeds intended for debt repayment and stock repurchases.
NYSE
Healthcare Realty Trust reported strong Q1 2026 operational results and increased its full-year 2026 guidance for Normalized FFO and Same Store Cash NOI growth.
NYSE
Healthcare Realty Trust Incorporated published a business update presentation highlighting strong 2025 financial performance, strategic achievements, and a positive outlook for its outpatient medical REIT portfolio.
NYSE
Healthcare Realty Trust Incorporated has appointed Deloitte & Touche LLP as its new independent registered public accounting firm, replacing BDO USA, P.C., effective February 19, 2026.
NYSE
Healthcare Realty Trust reported a GAAP net income of $0.04 per share for Q4 2025 and introduced 2026 guidance, alongside establishing a new $600 million commercial paper program.
NYSE
Healthcare Realty Trust announced the appointment of Daniel Gabbay as its new Executive Vice President and Chief Financial Officer, effective January 12, 2026, replacing Austen B. Helfrich.
NYSE
Healthcare Realty Trust Incorporated has established a new 'at-the-market' equity offering program to raise up to $1 billion for general corporate purposes, including acquisitions and development.
NYSE
Healthcare Realty Trust reported robust third-quarter results, exceeding prior guidance with strong same-store NOI growth and proactive balance sheet management.
NYSE
Healthcare Realty Trust announced improved second-quarter 2025 financial and operating results, raised its full-year guidance, and detailed a comprehensive strategic plan focused on portfolio optimization, debt reduction, and enhanced shareholder value.
NYSE
Healthcare Realty Trust Incorporated and its operating partnership have entered into a Fifth Amended and Restated Revolving Credit and Term Loan Agreement, totaling approximately $2.54 billion, which extends key debt maturities and maintains financial flexibility.
NYSE
Healthcare Realty Trust Incorporated announced a reduction in its Board of Directors from 12 to 7 members, effective June 18, 2025, as part of an effort to align with REIT industry corporate governance best practices.
NYSE
Healthcare Realty Trust Incorporated appoints Peter A. Scott to its Board of Directors and announces the results of its annual meeting of stockholders held on May 20, 2025.
NYSE
Healthcare Realty Trust Incorporated (NYSE:HR) announced its Q1 2025 results, reporting a net loss attributable to common stockholders of $(44.9) million, while reaffirming its full-year guidance.
NYSE
Healthcare Realty Trust Incorporated has appointed Peter A. Scott as its new President and Chief Executive Officer, effective April 15, 2025, succeeding Constance B. Moore who will transition out of the interim role and remain on the Board.
NYSE
Healthcare Realty Trust announces participation in Citi's 2025 Global Property CEO Conference and provides an update on rent collection from Prospect Medical, which is currently in bankruptcy.
NYSE
Healthcare Realty Trust reported a net loss for Q4 2024 but achieved normalized FFO per share at the high end of guidance and announced a quarterly dividend of $0.31 per share.
NYSE
Healthcare Realty Trust has amended its previous executive transition announcement, detailing a new employment agreement for its former General Counsel, John M. Bryant, Jr., as Senior Vice President, Legal Affairs.
NYSE
Healthcare Realty Trust has appointed three new independent directors, David Henry, Glenn Rufrano, and Don Wood, to its board as part of a cooperation agreement with Starboard Value LP.
NYSE
Healthcare Realty Trust has appointed Austen Helfrich as permanent CFO and Andrew Loope as General Counsel, succeeding John Bryant, as part of a planned leadership transition.
NYSE
Healthcare Realty Trust has formalized the appointment of Constance B. Moore as Interim President and CEO, outlining her compensation and terms of service in a new agreement.
NYSE
Healthcare Realty Trust announces the departure of CEO Todd Meredith and appoints Constance Moore as interim CEO, effective immediately.
NYSE
Healthcare Realty Trust reported a net loss for the third quarter, but saw growth in normalized FFO per share and made significant progress in capital allocation and occupancy.
NYSE
Healthcare Realty Trust announced a quarterly cash dividend of $0.31 per share for its common stock, payable on November 27, 2024.
NYSE
Healthcare Realty Trust has amended employment agreements for its newly appointed executives, effective October 1, 2024.
NYSE
Healthcare Realty Trust has announced key leadership changes, including a new interim CFO, COO, CAO, and CIO, while reaffirming its full-year 2024 guidance.
NYSE
Healthcare Realty Trust has expanded its joint venture with Nuveen Real Estate, bringing total year-to-date proceeds from joint ventures and asset sales to approximately $700 million.